Mirador Capital Partners’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-110,000
Closed -$36.6K 202
2024
Q2
$36.6K Hold
110,000
0.01% 187
2024
Q1
$25.3K Hold
110,000
﹤0.01% 194
2023
Q4
$35.1K Hold
110,000
0.01% 183
2023
Q3
$29.7K Buy
110,000
+49,961
+83% +$18.2K 0.01% 182
2023
Q2
$30.3K Hold
60,039
0.01% 188
2023
Q1
$39.5K Hold
60,039
0.01% 187
2022
Q4
$20.8K Sell
60,039
-10,000
-14% -$4.06K ﹤0.01% 191
2022
Q3
$31K Hold
70,039
0.01% 189
2022
Q2
$28K Hold
70,039
0.01% 186
2022
Q1
$44K Hold
70,039
0.01% 202
2021
Q4
$78K Buy
70,039
+31,500
+82% +$48.7K 0.02% 212
2021
Q3
$71K Hold
38,539
0.02% 199
2021
Q2
$122K Buy
+38,539
New +$96.3K 0.03% 196
2021
Q1
Sell
-13,539
Closed -$8K 192
2020
Q4
$8K Buy
+13,539
New +$6.19K ﹤0.01% 169
2019
Q4
Sell
-1,538
Closed -$12K 190
2019
Q3
$12K Buy
1,538
+769
+100% +$10.5K 0.01% 166
2019
Q2
$14K Buy
+769
New +$16.8K 0.01% 163

Other funds holding ASXC

Mirador Capital Partners's ASXC Position: Q3 2024 in Review

Mirador Capital Partners sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 110,000 shares — an estimated $36.6K sold.

Mirador Capital Partners first reported a position in ASXC in Q2 2019 and held it in 16 quarters. The position peaked at $122K in Q2 2021. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.

  • Mirador Capital Partners reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
  • Mirador Capital Partners sold 110,000 Asensus Surgical, Inc. shares in Q3 2024, an estimated $36.6K.
  • Mirador Capital Partners first reported a position in Asensus Surgical, Inc. in Q2 2019 and held it in 16 quarters.
  • Mirador Capital Partners's Asensus Surgical, Inc. position peaked at $122K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.

Based on Mirador Capital Partners's 13F filing for Q3 2024, filed 4 Oct 2024.